Can Stem Cells Help with Arthritis?

Stem cells are being tested as an experimental therapy for cartilage regeneration. MSCs, which are generated from umbilical cord blood, may travel to injured or inflammatory areas of the body and release a variety of regenerative factors, including vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) (PDGF).

These may help cartilage and supporting tissue develop faster, resulting in better tissue healing. They also have a variety of additional, more subtle impacts. They may, for example, decrease the severity of inflammation and avoid an overactive immune response.

Stem cells have anti-inflammatory properties

MSCs, for example, counteract the effects of many inflammatory chemicals and boost the production of TNF-stimulated gene/protein 6 (TSG-6), a protein with several anti-inflammatory activities. This suppresses the pro-inflammatory cascade by reducing macrophage inflammatory signals.

MSCs exposed to inflammatory chemicals produced by injured tissues, such as lipopolysaccharide, TNF-, or nitric oxide, give negative feedback by producing prostaglandin E2 (PGE2). This results in a change in macrophage phenotype from pro-inflammatory to anti-inflammatory. More mechanisms, perhaps involving proteins like stanniocalcin-1, that counteract the harm produced by reactive oxygen species may be discovered (ROS).

When cartilage cells are grown with stem cells, they develop more quickly, and the extracellular matrix (ECM) they secrete around themselves is more stable and comparable to that seen in real cartilage. Infusing umbilical cord MSCs seems to be linked with the highest degree of improvement, at least in rheumatoid arthritis, based on existing information. Most stem cell treatments available today, however, utilise fat or bone marrow injections, which are not the ideal kind of stem cells in this situation since stem cells make up a tiny proportion of the overall number of cells infused.

If you are looking for a reliable stem cell treatment provider in India to help you with arthritis trouble, then connect with Stem Cell Care India, to know more!

What Is The Best Treatment For Muscular Dystrophy?

Muscular dystrophy is a nerve and muscular disorder. The optimal therapy for muscular dystrophy is determined on the kind and stage of the disease. Physical therapy, medication, and surgery are used to treat it.

Muscular dystrophy has no cure, however therapy may help you retain your independence while also strengthening your muscles. It is feasible to retain a high quality of life with an early diagnosis.

Muscular dystrophy is a neurological and muscular disorder. It is generally inherited, and it is diagnosed between the ages of two and five years old. Muscular dystrophy often manifests itself initially in the shoulders and pelvis.

Muscular dystrophy will ultimately spread throughout the body, affecting key nerves and muscle groups, even if it takes many years.

Muscular dystrophy signs and symptoms

At an early age, children with muscular dystrophy will generally have difficulty moving about. They may not be able to sit up, roll over, crawl, or walk as quickly as other kids. Because muscular dystrophy starts in the shoulders and pelvis, these motions are immediately impacted.

The following symptoms may appear gradually in older children and adults:

  • Difficulty going uphill or ascending stairs • Inability to leap or hop • Clumsiness, stumbling, and falling
  • Weakness in the upper body, especially shoulders • Toe walking • Pain in the pelvis or legs

Additional difficulties may arise as the illness develops due to muscular weakening. You may have heart and lung issues, as well as scoliosis.

Muscular Dystrophy Causes

Muscular dystrophy is a hereditary condition. It is caused by incorrect or missing genetic information. These faulty genes hinder your body from producing the proteins required for proper muscular development and growth.

Who is at risk for muscular dystrophy?

Muscular dystrophy may affect anybody. However, since it is a progressive hereditary illness, it is most often identified in young children. Adulthood diagnoses are not rare for some people who discover symptoms later in life.

Muscular dystrophy diagnosis

Your doctor may be hesitant to diagnose muscular dystrophy in youngsters at first. Rather than dystrophy, the disease’s symptoms may indicate delayed muscular development. Your doctor may initially send your kid to physical therapy to help strengthen his or her muscles.

A blood test will reveal genetic markers that indicate to muscular dystrophy if your family has a history of the illness. Other tests that are available include:

  • Muscle biopsy: A sample of muscle tissue is examined under a microscope for indications of deterioration.
  • Genetic testing: If no family history of muscular dystrophy is known, genetic tests may search for markers that indicate the risk of acquiring the disease.
  • Neurological tests: An ECG or an echocardiography may be used to monitor your heartbeat and check for irregularities in the way your muscles function.
  • Exercise tests: To determine how muscular dystrophy affects your body, your doctor may want to evaluate your strength.
  • Imaging studies, such as magnetic resonance imaging (MRI) and ultrasound scans, to determine the fat composition in your muscles.

Muscular dystrophy treatments

The optimal therapy for muscular dystrophy is determined on the kind of dystrophy you have and how far it has progressed in your body. To control your present symptoms and avoid future harm, your treatment strategy will most likely involve a mix of medication and therapy.

Physical therapy is a kind of treatment that is used

The greatest approach to avoid additional muscle deterioration is to maintain physical independence. As a result, for individuals with muscular dystrophy, physical treatment is strongly advised. A physical therapist can assist you or your kid in focusing their efforts on the disease’s particular muscle areas. These treatments may help you gain strength over time.

Orthotic braces are also often used to support joints such as the hips and knees. This helps to relieve joint strain and promote appropriate mobility. Without the need of a wheelchair or walker, braces may let you walk and move about independently.

Medication

Although pain medication may be given, there is no cure for the illness. Breathing care will be required at some point when the heart and respiratory muscles deteriorate as a result of muscular dystrophy.

Surgery

If you have muscular dystrophy with scoliosis, you may need surgery to restore your spinal alignment. Your vertebrae may be fused together by a surgeon to straighten your spine and prevent future injury.

Things to Know About Stem Cell Therapy for Cerebral Palsy

Cerebral palsy (CP) is a non-progressive neurological disease that causes an inability to execute motions owing to a lack of muscular coordination or excessive muscular stiffness. Cerebral Palsy does not become worse with time (non-progressive). However, as the kid develops, the limb or portion linked with the injured portion may suffer a gradual loss of function. These areas of the body may not develop as much as the rest of the body.

For children with cerebral palsy, stem cell therapy is a potential therapeutic option. However, this therapy is still in its early stages, and further study is needed. Clinical studies of this treatment are under underway in Georgia and Texas.

What Are Stem Cells and How Do They Work?

Stem cells are primordial cells with the capacity to differentiate into many cell types and, as a result, create various tissues. There are two kinds of stem cells: adipose stem cells and mesenchymal stem cells.

Adult Stem Cells (ASCs)

Adult stem cells are present in fully developed individuals and are capable of providing new cells to heal damaged tissues.

Embryonic Stem Cells (ESCs) are stem cells derived from embryos.

Embryonic stem cells (ESCs) are stem cells that form during the early stages of development. ESCs form in the blastocyst mass and may spread and expand into a variety of cell types.

What is a Stem Cell Transplant for Cerebral Palsy Children?

A physician injects stem cells into a kid either intravenously, via a vein, or intrathecally, through a lumbar puncture into the spinal column, during a stem cell transplant.

The goal is for the stem cells to mature into nerve cells capable of forming connections with other cells.

Additionally, after the cells have formed connections with other cells, they must be able to communicate with the muscles that govern movement. The effectiveness of the therapy hinges on this development.

After stem cell treatment, physical rehabilitation is nearly always recommended. While medical experts say it’s impossible to say whether stem cell treatment or physical therapy is more beneficial, combining the two offers the kid the greatest chance of success.

Learn More About Cerebral Palsy Through Stem Cell Research

Pluripotent stem cells, such as embryonic stem cells, are being researched and utilised to generate many kinds of brain cells. These cells may be useful in learning more about how cerebral palsy operates. As a result, medical experts are looking for new and better treatment options.

Drugs to Help Target Children’s Brain Stem Cells

Medication that may promote the creation of new stem cells in the body is also being studied. The child’s own stem cells would be utilised to mend their damaged tissues in this kind of therapy. This study is now in the clinical trial stage, which means the researchers are trying to figure out whether the treatment is safe for all patients.

Role Of Stem Cell Therapy In Post-COVID Lungs Fibrosis

What is Chronic Obstructive Pulmonary Disease? (COPD or Lung Disease)

Chronic Obstructive Pulmonary Disease (COPD or Lung Disease) is a term that refers to a collection of lung ailments (diseases) that may make it difficult for the body to expel air from the lungs. Symptoms of COPD include tiredness and shortness of breath (breathlessness). A person with emphysema, chronic bronchitis, or a mix of the two may be diagnosed with chronic obstructive pulmonary disease (COPD or Lung Disease).

Tobacco smoke, either active or secondhand smoke, is the main cause of Chronic Obstructive Pulmonary Disease (COPD or Lung Disease). Inhaling smoke or other airborne irritants or pollutants may cause mucus production to rise in the bronchial tubes (bronchi), resulting in inflammation and thickening of the bronchial walls. Coughing often, resulting in mucus production, is a symptom of excessive mucus production in the bronchial tubes (phlegm). When pollutants are breathed in excess, COPD may develop over time or in a short amount of time.

Other environmental variables, such as dust, air pollution, and airborne pollutants, may induce Chronic Obstructive Pulmonary Disease (COPD or Lung Disease).

The diagnosis of Chronic Obstructive Pulmonary Disease (COPD or Lung Disease)

“Chronic bronchitis and emphysema are both part of chronic obstructive pulmonary disease (COPD). Most people with COPD have a little bit of both, but one or the other predominates. Your doctor will inquire about your family’s history of respiratory diseases, your symptoms, and the medications you’re taking, as well as your lifestyle. To diagnose and evaluate the severity of your COPD, he or she will do a physical exam and request certain laboratory tests.

Chronic Obstructive Pulmonary Disease (COPD) was predicted to affect 13.1 million people in the United States in 2008. (COPD or Lung Disease). However, over 24 million people in the United States show signs of decreased lung function, suggesting a chronic obstructive pulmonary disease (COPD) underdiagnosis (COPD or Lung Disease).

In 2008, an estimated 9.8 million Americans were diagnosed with chronic bronchitis, which causes inflammation and scarring of the bronchial tubes’ lining. Chronic bronchitis affects individuals of all ages, although the incidence is greatest among those 65 and older, at 56.3 per 1,000 people.”

SARS-COV 2 (Severe Acute Respiratory Syndrome Coronavirus) causes COVID-19, an acute respiratory viral illness that has spread globally. COVID-19 is primarily responsible for Acute Respiratory Distress Syndrome (ARDS) respiratory problems, cytokine storm, and severe immunological disturbances. The tests show that even when individuals recover from COVID-19, symptoms remain in the body, producing pain, which is a result of the viral infection caused by significant immunological abnormalities. Following the COVID-19 challenges, pulmonary fibrosis has become a stumbling block in the lungs, inflicting significant damage. We have demonstrated the efficacy and importance of the Hepatocyte Growth Factor (HGF) secreted by Mesenchymal Stem Cell (MSC) therapy on selective stoppage of the Transforming Growth Factor-Beta (TGF-) signalling pathway by causing immunomodulatory effects that alleviate pulmonary fibrosis via paracrine signalling in this review. More pilot trials, however, are needed to establish the effectiveness and effects of the resurfacing complication.

Is Stem Cell Therapy Effective in Liver Cirrhosis?

What is cirrhosis of the liver?

Cirrhosis of the liver develops over time as a consequence of illness or chemical-induced liver damage. Your body tries to repair the damage as the injuries destroy liver cells. Existing cells become irritated, and scar tissue forms, jeopardising the structure of the liver and impairing its function. Cirrhosis may develop in your liver as a result of a disease or poisons, such as alcohol. Cirrhosis may be caused by a liver processing problem or an autoimmune disease, which causes the body’s defence systems to attack liver tissue. Although there are treatments to reduce the scarring and enhance function, the scarring caused by liver cirrhosis is irreversible.

What is the therapy for cirrhosis of the liver?

Cirrhosis treatment varies based on the degree of the liver malfunction and may include: • Preventing additional liver damage • Treating cirrhosis complications • Preventing or detecting liver cancer early • Liver transplant • Eating a well-balanced diet and taking a multivitamin daily Patients with PBC who have trouble absorbing fat-soluble vitamins may need extra vitamin D and K.

  • Avoiding liver-damaging substances (including alcohol).
  • Alcohol should be avoided by anybody with cirrhosis. Abstinence from alcohol improves liver function in the majority of people with alcohol-induced cirrhosis. Abstinence from alcohol may significantly decrease liver damage and delay the development of cirrhosis in individuals with chronic hepatitis B and C.
  • Staying away from nonsteroidal anti-inflammatory medications (NSAIDs) (NSAIDs, such as ibuprofen or naproxen). NSAIDs may cause cirrhosis patients’ liver and kidney function to deteriorate.
  • Using antiviral medicines to eradicate the hepatitis C virus. Drug therapy is not appropriate for all individuals with cirrhosis caused by persistent viral hepatitis. During therapy, some individuals may develop severe liver dysfunction and/or unacceptable adverse effects. Treatment for viral hepatitis must be decided on an individual basis after consultation with physicians who specialise in the treatment of liver disorders (hepatologists).
  • Removing blood from individuals with hemochromatosis in order to lower iron levels and avoid additional liver damage. In Wilson disease, medicines may be used to enhance copper excretion in the urine, lowering copper levels in the body and preventing additional liver damage.
  • Suppressing the immune system with medicines like prednisone and azathioprine (Imuran) to reduce autoimmune hepatitis liver inflammation.
  • Ursodeoxycholic acid (UDCA), commonly known as ursodiol, is a bile acid formulation used to treat individuals with PBC (Actigall). An study that pooled the findings of multiple clinical studies found that UDCA improved survival in PBC patients over the course of four years of treatment. UDCA also helped to prevent the onset of portal hypertension. Despite its obvious advantages, UDCA therapy just delays the development of PBC rather than curing it. Colchicine (Colcrys) and methotrexate (Rheumatrex, Trexall) are two more medicines that may help certain people with PBC.
  • Immunizing individuals with cirrhosis against hepatitis A and B infection in order to avoid severe liver damage. There are no vaccinations available to protect against hepatitis C at this time. What kind of doctor treats liver cirrhosis?

Hepatology is the study of liver disease, and in the treatment of liver cirrhosis, a liver specialist or hepatologist will most likely be part of your medical team. Gastroenterology has a speciality called hepatology (GI doctor). The liver is the body’s largest internal organ, and hepatology studies acute and chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, liver transplantation, drug metabolism (which is heavily dependent on the liver), and liver immunology.

How Successful Is Stem Cell Treatment For Retinitis Pigmentosa?

Retinitis pigmentosa (RP) is a genetic illness that causes vision loss and eventually blindness. Gene therapy, stem cell therapy, and visual prosthesis are some of the therapeutic options. However, none of these techniques can overcome their inherent limits in a short amount of time. Patients with RP have lower levels of vascular endothelial growth factor (VEGF) and pigment epithelium derived factor (PEDF) in their aqueous humour. However, exogenous nerve growth factors (NGFs) were previously thought to be immunogenic proteins that may induce inflammation. Because autoserum contains so many active components, it will not produce an exclusive response. The goal of this research is to examine and evaluate the therapeutic efficacy and safety of autoserum injections in the retrobulbar area for the treatment of retinitis pigmentosa.

RP is a rare hereditary condition that causes the rods and cones, the light-sensing cells at the rear of the eye, to progressively die. The picture on the left depicts normal vision, whereas the one on the right depicts what occurs with RP. You lose your night vision first, then other aspects of your eyesight deteriorate until you are legally blind.

People with RP are typically diagnosed in their teens and are legally blind by the time they reach middle age. There is no therapy or cure for this disease. It is believed that 100,000 individuals in the United States and two million people globally have RP.

The safety profile of a new stem-cell-derived therapy intended to maintain and possibly restore eyesight in individuals with retinitis pigmentosa (RP) has been shown in an ongoing study.

Given that this is one of the first trials of a stem-cell-derived treatment for RP, this safety data is welcome news and a significant step forward. As the experiment progresses, we at the Foundation anticipate further findings from this study in the following years.

The treatment entails injecting retinal progenitors, which are stem cells in the process of developing into retinal cells, into the vitreous, the gel-like material in the centre of the eye. The cells are expected to produce proteins that will maintain the patient’s current photoreceptors healthy, avoiding degeneration and preserving eyesight, according to the researchers. The proteins may also help cones that have ceased processing light but haven’t completely deteriorated, according to the researchers. Cones are photoreceptors that allow us to read, identify faces, and see in dimly lit environments. Viezec offers the best stem cell therapy for Retinitis Pigmentosa.

How Effective Is Stem Cell Therapy For Stroke Patients?

Stroke patients may benefit from stem cell treatment. Stem cells are an exciting new therapeutic option that has been shown safe and beneficial in many peer-reviewed research. It prevents additional harm to the body and brain after a stroke by rebuilding damaged brain cells and controlling the immune system. Stem cell treatment for stroke survivors is a useful alternative treatment option because of these features.

What exactly is a stroke?

A stroke happens when blood flow to the brain is interrupted, depriving the brain of oxygen for a short period of time.

Every year, approximately 795,000 individuals in the United States suffer from strokes, which may strike at any age. Until recently, there was little that could be done to prevent brain damage from a stroke if it was not detected early and treated within hours of its onset. Recent research and clinical trials using stem cells on actual stroke patients, on the other hand, have shown incredible outcomes.

What is the cause of a stroke?

A stroke may result from a lack of blood flow to the brain (ischemic) or from a haemorrhage (bleeding within the brain).

What is an Ischemic Stroke, and how does it happen?

Ischemic strokes, on the other hand, are produced by tiny blockages in the blood artery. These are often plaque fragments or blood clots. Annually, ischemic strokes account for approximately 87 percent of all strokes. In either instance, cutting off blood supply to the brain causes brain cells to die within minutes, potentially resulting in long-term brain damage and neurological problems. To dissolve the blood clot, conventional therapies such as tissue plasminogen activators (tPA) were utilised till recently. They are generally useless in avoiding long-term impairment if not given within hours after a stroke.

What is stem cell treatment and how does it work?

Stem cell therapy is a non-invasive procedure for replacing damaged cells in the body. Mesenchymal stem cells may be injected locally or systemically to target particular areas, depending on the requirements of the patient.

Because of their anti-inflammatory and immunoregulatory properties, stem cells may be able to assist stroke victims. Stroke may be treated safely using stem cell therapy. If given early enough, stem cell therapy may help in stroke recovery. (1)

Can stem cells assist those who have had a stroke?

Stem cells are regenerative and anti-inflammatory by nature, and they seek out damaged tissue in the body. As a result, Stanford University School of Medicine used stem cells in clinical studies to treat stroke patients of various ages, ranging from 6 months to 3 years following their stroke. The study included 18 people, with an average age of 61, and utilised direct brain stem cell transplantation.

The stem cells used in the research were taken from a donor’s bone marrow. All of the individuals exhibited indications of better motor function after just a few months. The Fugl-Meyer Assessment, a stroke-specific impairment test, revealed an average gain of 11.4 points in the patients, and the effects lasted for years following therapy, as tracked by the institution. This study made significant progress in demonstrating that stem cells may successfully treat stroke symptoms years after the stroke has occurred, and that they can be used at any age.

Does Stem Cell Therapy Work For Optic Nerve Atrophy?

Unique Access gives patients access to a comprehensive treatment plan for Optic Nerve Atrophy (ONA) that includes larger doses of stem cells, novel stem cell growth factors, intensive rehabilitation, and a variety of supporting treatments and supplements. Patients have seen substantial benefits because to this successful mix of cutting-edge medical technology and functional therapy.

Why Are Stem Cells Effective in the Treatment of Optic Nerve Atrophy? (ONA)

After being injected into the retrobulbar area, the stem cells may begin detecting damaged tissue signals.

Photoreceptors and other cells may be differentiated from Mesenchymal Stem Cells (MSCs). The differentiated cells may one day be used to treat optic nerve and retinal pigment cell diseases.

This therapy may repair part of the fibres via lost optic nerve cells in individuals with Optic Nerve Injuries or Optic Nerve Atrophy (ONA), improving eyesight, field of vision, and colour discrimination ability.

Mechanisms

Based on their many distinctive features, Mesenchymal Stem Cells (MSCs) may enhance eyesight via the following mechanisms:

(1) MSCs can differentiate into neural cells and secrete neurotrophic factors like brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factors (GDNF), which can help grafted cells differentiate into neural cells, inhibit apoptosis, improve angiogenesis, suppress an inflammatory infiltrate, and maintain grafted cell survival.

Through the regeneration of optic nerve and retinal ganglion cells, these processes not only assist to preserve vision, but also to substantially improve lost eyesight.

Improvements

The majority of patients with optic nerve atrophy who have been treated by Global Stem Cells have had access to novel therapies. Adult MSCs improved visual acuity, visual field, light sensitivity, night vision, strabismus, and nystagmus.

Furthermore, stem cell therapy substantially reduced the progression of visual loss in individuals with progressive diseases.

Patients with Optic Nerve Atrophy (ONA) who get stem cell treatment typically see improvements in the following areas:

  • Nystagmus
  • Visual acuity
  • Light perception
  • Field of vision
  • Night vision
  • Color vision

Our Commitment

We think that patients deserve access to effective and safe therapies and that there is always hope.

We are self-contained and have our own medical department.

To guarantee the greatest possible treatment outcomes, we combine globally recognised facilities, next-generation therapies, innovative goods and services that are integrative and successful.

In terms of stem cells, we will ensure that the patient receives the proper kind, quality, amount, and viability of stem cells. Our exclusive research partner guarantees a stem cell viability of 95%, with several injections reaching a remarkable 98-99% vitality.

Supportive Therapies & Remedies are a kind of therapy that is used to help people who are suffering from

We make certain that the patient receives the necessary supporting medicines, therapies, rehabilitation, detoxification, and immune-boosting programmes in order to get the most out of the stem cells. These are some of the programmes:

Hyperbaric Oxygen Chamber (HBOT)

Acupuncture

Aquatic Therapy

Physiotherapy Treatment

Occupational Therapy

Transcranial Magnetic Stimulation (rTMS)

Hemo Oxygen Therapy (HOT)

IV Vitamin Drips

Immune-Boosting Supplements (e.g. GcMAF)

Special Diet Plans & Consultations

Does Stem Cell Therapy for Chronic Kidney Disease Work?

Kidney transplantation is becoming more popular. High blood pressure and type 2 diabetes are on the rise in the Western world, leading to an increase in kidney disease rates. However, there aren’t enough organ donors to satisfy the demand. Stem cell-based treatments may be a viable option.

Kidney failure affects more than 660,000 Americans each year, resulting in roughly 47,000 fatalities. Despite the fact that kidney failure may be caused by a variety of factors, the current therapy is rather consistent. While waiting for a transplant, patients often need weekly dialysis, which may cost up to $80,000 per year. Thankfully, advancements in stem cell research have yielded some promising results in the treatment of renal failure.

Kidneys that are in good working order filter waste and surplus fluids from the body. Various diseases, however, may harm the kidneys, causing an accumulation of excess fluids, waste, and electrolytes. This may have a variety of negative effects on the body. Even while the kidneys have a limited capacity to regenerate on their own, the damage produced by kidney disease ultimately overwhelms the organs. As a consequence, the patient requires external dialysis to survive and, ultimately, a complete organ transplant. Kidney disease has several causes, but diabetes is responsible for almost half of all kidney failure cases.

What role do stem cells play in the treatment of renal disease?

Stem cell treatment is anti-inflammatory, lowering chronic inflammation levels in the body to levels that enable healing to take place when it would otherwise be impossible. Inflammation levels would be high throughout the body if you have Kidney Disease. The body may begin to repair the tissue needed for proper function by decreasing inflammatory indicators to normal levels.

Kidney failure stem cell treatment

Scientists are trying to figure out how to replenish the cells in the kidneys that help in organ regeneration. Specific mesenchymal cells, a kind of stem cell that plays an important role in kidney repair, have recently been discovered by Harvard Stem Cell Institute researchers. These stem cells may be implanted into the body to stimulate kidney tissue repair and decrease overall inflammation. Furthermore, stem cells have previously been utilised in combination with organ transplants to remove the need for immunosuppressive medications for the rest of one’s life.

Is it possible to treat renal illness using stem cells?

Kidney disease is difficult to research and treat since the kidneys are complex organs that perform important filtering tasks in the body. Because scientists have yet to identify the particular cells responsible for kidney healing, only broad systemic stem cell treatment is now available to address these problems.

A realistic result of stem cell therapy would be a significant decrease in inflammatory markers and a modest improvement in kidney function when compared to pre-treatment values. This would probably not be enough to get a patient off dialysis after only one treatment, but it would be a start toward reducing dialysis frequency.

Diabetes and Stem Cell Therapy treatment by stem cell care india - new delhi

Diabetes and Stem Cell Therapy

For many people, managing diabetes is a daily battle. It can necessitate near-constant forethought about when and what a person will eat throughout the day, whether or not the meals will require insulin, countless finger pricks to check glucose levels, and the added inconvenience of constantly carrying insulin pumps and testers, extra batteries, and everything else they will need to get through the day.

Diabetes is a group of illnesses in which the body’s ability to make or utilise insulin, the hormone needed to turn food into energy, is impaired. Diabetes has no recognised cause, and there is currently no cure. In the United States today, diabetes is the sixth greatest cause of mortality.

The American Diabetes Association claims that “Diabetes affects 23.6 million children and adults in the United States, accounting for 7.8% of the population. Despite the fact that 17.9 million individuals have been diagnosed with diabetes, 5.7 million people (almost a quarter) remain ignorant that they have it.”

There are three kinds of diabetes: type 1 diabetes, type 2 diabetes, and type 3 diabetes.

Type 1 is an autoimmune illness, whereas Type 2 is linked to genetic and lifestyle factors.

  • Gestational diabetes is a kind of diabetes that develops during pregnancy.

The inability of the body to generate insulin causes Type 1 Diabetes, which requires daily insulin injections. It’s frequently referred to as “juvenile diabetes” since it most often affects youngsters. According to the Juvenile Diabetes Research Foundation (JDRF), up to three million Americans may have type 1 diabetes (T1D), with an average of 40 youngsters diagnosed each day (more than 15,000 per year).

The key to treating diabetes is to keep insulin levels stable. Today’s conventional therapy is boosting the body’s insulin levels, usually with injections (needles) or insulin pumps worn outside the body. This necessitates the patient checking his or her blood sugar levels many times each day and monitoring blood insulin levels closely. While this is presently the best standard of treatment, researchers are hoping to discover a method to aid the body’s ability to generate or control its own insulin levels.

One approach under investigation is the use of stem cells to generate insulin-producing islets in the pancreas. While stem cell treatment has yet to cure type 1 diabetes, individuals have gone years without requiring insulin injections. Cord blood stem cells are being used in certain clinical studies to treat diabetes.

Treatment of Type 2 Diabetes using Stem Cells

Researchers collected and evaluated 13 papers published between 2006 and 2016 that included 342 patients who got stem cells similar to those found in cord blood and another 111 who received stem cells similar to those found in cord tissue to treat their diabetes. Despite the fact that not everyone reacted to the therapy, researchers found that it improved glucose control and decreased insulin need for up to four years. While the findings indicated promise for utilising stem cells to treat diabetes, they left a few issues unresolved, such as who were the best candidates, what was the best method of delivery, what was the optimum dosage, and if repeated transfusions were required.